Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
CVS
Financials
Revenue by product
CVS
CVS Health Corporation
Backtest
CVS
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by product
Annual
Quarterly
Revenue by product
Annual
Quarterly
2025, ended Dec 31, 2025
Products
$249.9B
62%
Services
$15.2B
4%
Other
$137.0B
34%
Earlier:
Premiums
to 2016
Products by fiscal year
CSV
Products by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Products
249.9B
231.5B
245.1B
226.6B
203.7B
190.7B
185.2B
183.9B
180.1B
173.4B
Services
15.2B
16.2B
12.3B
9.7B
11.0B
7.9B
7.4B
1.8B
1.1B
1.1B
Other
137.0B
125.0B
100.3B
86.2B
77.3B
70.2B
64.1B
8.8B
3.6B
—
Earlier
Premiums
—
—
—
—
—
—
—
—
—
3.07B
Total
402.1B
372.8B
357.8B
322.5B
292.1B
268.7B
256.8B
194.6B
184.8B
177.5B
More CVS Health financials
Revenue
Gross profit
Operating income
Net income
EPS
EBITDA
Revenue at other companies
DHR
Danaher Corporation
SYK
Stryker Corporation
BMY
Bristol-Myers Squibb Company
MCK
McKesson Corporation
BSX
Boston Scientific Corporation
VRTX
Vertex Pharmaceuticals Incorporated
Tools
Return calculator